Complete	complete	O	O	O	O
atrioventricular	atrioventricular	O	DISEASE	OTHERS	I
block	block	O	DISEASE	OTHERS	I
secondary	secondary	O	O	O	O
to	to	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Sinus	sinus	O	O	OTHERS	I
node	node	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
most	most	O	O	O	O
frequently	frequently	O	O	O	O
among	among	O	O	O	O
the	the	O	O	O	O
adverse	adverse	O	O	O	O
cardiovascular	cardiovascular	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
case	case	O	O	O	O
,	,	O	O	O	O
complete	complete	O	O	O	O
atrioventricular	atrioventricular	O	O	OTHERS	I
(	(	O	O	OTHERS	I
AV	av	O	O	OTHERS	I
)	)	O	O	OTHERS	I
block	block	O	O	OTHERS	I
with	with	O	O	O	O
syncopal	syncopal	O	O	OTHERS	I
attacks	attacks	O	O	OTHERS	I
developed	developed	O	O	O	O
secondary	secondary	O	O	O	O
to	to	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
,	,	O	O	O	O
necessitating	necessitating	O	O	O	O
permanent	permanent	O	O	O	O
pacemaker	pacemaker	O	O	O	O
implantation	implantation	O	O	O	O
.	.	O	O	O	O

Serum	serum	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
remained	remained	O	O	O	O
under	under	O	O	O	O
or	or	O	O	O	O
within	within	O	O	O	O
the	the	O	O	O	O
therapeutic	therapeutic	O	O	O	O
range	range	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
syncopal	syncopal	O	O	OTHERS	I
attacks	attacks	O	O	OTHERS	I
.	.	O	O	O	O

Lithium	lithium	CHEMICALS	O	OTHERS	I
should	should	O	O	O	O
be	be	O	O	O	O
used	used	O	O	O	O
with	with	O	O	O	O
extreme	extreme	O	O	O	O
caution	caution	O	O	O	O
,	,	O	O	O	O
especially	especially	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
mild	mild	O	O	O	O
disturbance	disturbance	O	O	O	O
of	of	O	O	O	O
AV	av	O	O	O	O
conduction	conduction	O	O	O	O
.	.	O	O	O	O

